Strides Pharma Science Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,220.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.03 per cent from ₹1,119.74 crore. This corresponds to a year-on-year *(YoY) growth of 4.62 per cent.
Operating Profit
Operating Profit stands at ₹73.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.51 per cent from ₹56.14 crore. This corresponds to a year-on-year *(YoY) decline of 28.33 per cent.
PBDT
PBDT stands at ₹71.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.01 per cent from ₹65.34 crore. This corresponds to a year-on-year *(YoY) growth of 14.17 per cent.
Profit Before Tax
Profit Before Tax stands at ₹153.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.45 per cent from ₹122.05 crore. This corresponds to a year-on-year *(YoY) growth of 77.60 per cent.
Net Profit
Net Profit stands at ₹136.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.23 per cent from ₹107.98 crore. This represents a 80.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | 0.44% | 2.66% | -9.71% | -12.92% | -6.76% | 18.89% |
| P & G Health Ltd | -0.82% | -2.10% | -7.01% | -14.14% | -10.14% | -1.55% |
| Viyash Scientific | -1.66% | -2.02% | -4.37% | -7.46% | 15.63% | 20.60% |
| Jeena Sikho | -1.56% | -3.24% | -5.97% | -13.96% | 19.25% | 19.25% |
| Marksans Pharma | -0.03% | -0.19% | -10.77% | -11.65% | -29.43% | -33.46% |
| Blue Jet Health | -1.78% | -1.86% | -22.25% | -37.22% | -48.88% | -45.07% |
| Sudeep Pharma | -0.55% | 8.51% | 0.68% | -21.60% | -21.60% | -21.60% |
Company Info
Company Information
Executive Chairman & Managing Director : Arun Kumar
Company Sec. & Compli. Officer : Manjula Ramamurthy
Non Executive & Independent Director : Homi Rustam Khusrokhan
Managing Director & Group CEO : Badree Komandur
Non Executive & Independent Director : Kausalya Santhanam
Non Executive & Independent Director : Subir Chakraborty
Non Executive & Independent Director : Ameet Hariani
Director (Business Development) : Aditya Kumar
Independent Director : Mukta Malik Arora